StockData
Silence Therapeutics plc logo

Silence Therapeutics plc (SLN) stock

SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$19.80+0.00 (0.00%)

Close on Nov 17, 2026Market cap $935.48MP/E –Yield –

Silence Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Silence Therapeutics

Silence Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Silence Therapeutics figures

See a number that looks wrong?